FMP

FMP

Enter

MIST - Milestone Pharmaceut...

Financial Summary of Milestone Pharmaceuticals Inc.(MIST), Milestone Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commerci

photo-url-https://financialmodelingprep.com/image-stock/MIST.png

Milestone Pharmaceuticals Inc.

MIST

NASDAQ

Milestone Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of cardiovascular medicines. The company is developing etripamil, a novel channel blocker, which is in Phase III clinical trial for the treatment of paroxysmal supraventricular tachycardia in the United States and Canada; and Phase II clinical trial for the treatment of atrial fibrillation and rapid ventricular rate. It has a license and collaboration agreement with Ji Xing Pharmaceuticals to develop and commercialize etripamil prophylactic and therapeutic uses in humans. The company was incorporated in 2003 and is headquartered in Montréal, Canada.

1.48 USD

-0.07 (-4.73%)

About

ceo

Mr. Joseph G. Oliveto M.B.A.

sector

Healthcare

industry

Biotechnology

exchange

NASDAQ

Description

Milestone Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of cardiovascular medicines. The company is developing etripamil, a novel channel blocker, which is in Phase III clinical trial for the treatment of paroxysmal supraventricular tachycardia in the United States and Canada; and Phase II clinical trial for the treatment of atrial fibrillation and rapid ventricular rate. It has a license and collaboration agreement with Ji Xing Pharmaceuticals to develop and commercialize etripamil prophylactic and therapeutic uses in humans. The company was incorporated in 2003 and is headquartered in Montréal, Canada.

CIK

0001408443

ISIN

CA59935V1076

CUSIP

59935V107

Address

1111 Dr. Frederik-Philips Boul...

Phone

15143360444

Country

CA

Employee

47

IPO Date

May 9, 2019

Summary

CIK

0001408443

Exchange

NASDAQ

Industry

Biotechnology

Sector

Healthcare

CUSIP

59935V107

ISIN

CA59935V1076

Country

CA

Price

1.48

Beta

1.64

Volume Avg.

157.56k

Market Cap

78.84M

Shares

-

52-Week

1.12-3.62

DCF

-0.9

ROE

-

ROA

-

Operating Margin

-

Debt/Equity

-

P/E

-1.18

P/B

-

Website

https://www.milestonepharma.com

Historical Prices

We are unable to load the chart at this time.

fmp-logo

Financial Statement

We are unable to load the chart at this time.

fmp-logo

Earnings

We are unable to load the chart at this time.

fmp-logo

Upgrades and Downgrades

We are unable to load this data!

fmp-logo

People Also Watch

page loading card

Latest MIST News

It looks like there's no news available.

fmp-logo
FMP

FMP

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.
twitterlinkedinfacebookinstagram
2017-2024 © Financial Modeling Prep